Main navigation About Philosophy Vision & Strategy Group Code of Conduct Astellas Pharma Israel Policies & Position Statements Ethics & Compliance Transparency Making an Impact Support for Medical Education Therapy Areas Therapy Areas Urology Oncology / Haematology Transplantation Women’s Health Astellas Products BETMIGA™ (mirabegron) XTANDI™ (enzalutamide) XOSPATA™ (gilteritinib) ADVAGRAF™ (tacrolimus prolonged release) PROGRAF™ (tacrolimus) PADCEV™ (enfortumab vedotin) VEOZA™ (fezolinetant) Innovation R & D Clinical Trials Approach Ethics & Principles Pipeline Investigator Sponsored Research Sustainability Global Sustainability Policy Sustainability Approach Access to Health Environment Modern Slavery Act Gender Pay Gap Report News News Media Contacts Social Media Code of Conduct Sitemap Home menu Header / Footer Header Contact Us Worldwide Career Footer Site map Privacy Notice Terms of Use Cookies Policy MAT-IL-NON-2023-00013